aurisco pharmaceutical co., ltd.-凯发k8官网登录vip
about
us
r&d
product
&
service
manufacturing
site
investor
relations
career
contact
us
凯发k8官网登录vip-凯发天生赢家一触即发官网
api
fdf
oligonucleotide cro&cdmo
tech platforms
enzalutamide tablets
strength：
40mg, 80mg
indication：
castration-resistant prostate cancer (crpc); metastatic castration-sensitive prostate cancer (mcspc).
网站地图
